Cargando…
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in SARS-CoV-2 positive candidates is usually delayed until the clinical resolution of the infection’s symptoms and a negative nasopharyngeal molecular test. However, prolonged SARS-CoV-2 positivity has been frequently observed in haemato...
Autores principales: | Oltolini, Chiara, Acerbis, Andrea, Orofino, Giorgio, Racca, Sara, Noviello, Maddalena, Dispinseri, Stefania, Clementi, Nicola, Piemontese, Simona, Xue, Elisabetta, Giglio, Fabio, Lupo Stanghellini, Maria Teresa, Diral, Elisa, Bruno, Alessandro, Tassi, Elena, Beretta, Valeria, Marzinotto, Ilaria, Scarlatti, Gabriella, Lampasona, Vito, Ardemagni, Anna, Sampaolo, Michela, Bonini, Chiara, Corti, Consuelo, Peccatori, Jacopo, Castagna, Antonella, Ciceri, Fabio, Greco, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242072/ https://www.ncbi.nlm.nih.gov/pubmed/37287986 http://dx.doi.org/10.3389/fimmu.2023.1184956 |
Ejemplares similares
-
Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023) -
Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020) -
Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020) -
Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020) -
So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)